Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant.
March 23, 2023
February 21, 2023
February 16, 2023
First AML Patient Transplanted with Vor Bio’s Trem-cel Demonstrated Durable Engraftment through Multiple Mylotarg™ Cycles at Initial Dose Level
March 15, 2023 at 2:05 PM EDT
March 13, 2023 at 1:20 PM EDT
Data Provided by Refinitiv. Minimum 15 minutes delayed.